Results 11 to 20 of about 4,220 (134)

Biological studies of clavine alkaloids targeting CNS receptors

open access: yesFrontiers in Psychiatry, 2023
In contrast to well established psychedelics such as lysergic acid diethylamide (LSD) and psilocybin, ergot alkaloids of the clavine subclass have not been thoroughly investigated, in spite of their broad occurrence in nature and their well-established ...
Nikhil R. Tasker   +2 more
doaj   +1 more source

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review

open access: yesPharmaceuticals, 2021
Despite many different kinds of substances available for depression treatment, depression itself still appears to be a clinical challenge. Recently, formerly illicit substances came to scientists’ attention, including lysergic acid diethylamide (LSD ...
Gniewko Więckiewicz   +4 more
doaj   +1 more source

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders

open access: yesCell Reports, 2023
Summary: Hallucinations limit widespread therapeutic use of psychedelics as rapidly acting antidepressants. Here we profiled the non-hallucinogenic lysergic acid diethylamide (LSD) analog 2-bromo-LSD (2-Br-LSD) at more than 33 aminergic G protein-coupled
Vern Lewis   +18 more
doaj   +1 more source

Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD

open access: yeseLife, 2021
Psychoactive drugs can transiently perturb brain physiology while preserving brain structure. The role of physiological state in shaping neural function can therefore be investigated through neuroimaging of pharmacologically induced effects.
Joshua B Burt   +7 more
doaj   +1 more source

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain

open access: yesSouth African Medical Journal, 2023
Healthcare providers face the challenging task of managing patients who suffer from chronic nociplastic pain conditions. Pain is a multidimensional experience, and the current approach to managing people in chronic pain often fails to meet the needs
J Van Der Walt, R Parker
doaj   +1 more source

Pengalaman Anak Jalanan Usia Remaja Dalam Perilaku Inhalasi Lysergic Acid Diethylamide

open access: yesJurnal Ilmu Keperawatan Anak, 2019
Seorang anak bisa menjadi anak jalanan tentu mempunyai hal yang melatarbelakangi dalam kehidupannya. Sehingga anak jalanan sangat rentan untuk terjerumus kedalam perilaku menyimpang salah satunya adalah perilaku inhalasi zat adiktif seperti Lysergic Acid
Chatarina Suryaningsih   +1 more
doaj   +1 more source

Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography–Tandem Mass Spectrometry Methods

open access: yesSeparations, 2023
Lysergic acid diethylamide (LSD) is a powerful hallucinogen. Its detection is limited by its low dosage; moreover, LSD is rapidly metabolized into 2-oxo-3-hydroxy-LSD (O-H-LSD).
Alexandra Dimitrova   +5 more
doaj   +1 more source

Psychedelics as a Treatment for Alzheimer’s Disease Dementia

open access: yesFrontiers in Synaptic Neuroscience, 2020
Currently, there are no disease-modifying treatments for Alzheimer’s disease (AD) or any other dementia subtype. The renaissance in psychedelic research in recent years, in particular studies involving psilocybin and lysergic acid diethylamide (LSD ...
Simon Andrew Vann Jones   +1 more
doaj   +1 more source

Acute effects of lysergic acid diethylamide (LSD) on resting brain function

open access: yesSwiss Medical Weekly, 2019
Lysergic acid diethylamide (LSD) is a potent hallucinogenic substance that was extensively investigated by psychiatrists during the 1950s and 1960s.
Felix Müller, Stefan Borgwardt
doaj   +1 more source

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1

open access: yesScientific Reports, 2021
Recent evidence suggests that psychedelic drugs can exert beneficial effects on anxiety, depression, and ethanol and nicotine abuse in humans. However, their hallucinogenic side-effects often preclude their clinical use.
Ramona M. Rodriguiz   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy